Clinical Trials at Clermont Oncology Center
As of September 2026, 13 paid clinical trials are recruiting at Clermont Oncology Center, located at 255 CITRUS TOWER BLVD, SUITE 100, CLERMONT, FL 34711-2756, phone (352) 536-6340 in Clermont, Florida. Active studies at this site cover conditions such as Crohn's Disease, Non-Small Cell Lung Cancer and Alzheimer's Disease. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
13 clinical trials at Clermont Oncology Center
·Clear filters·A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
GEMINI-NSCLC: NSCLC Biomarker Study
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
Visugromab in Cachexia International Trial
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Common conditions studied in Clermont
- Crohn's Disease (3 active studies)
- Non-Small Cell Lung Cancer (3 active studies)
- Alzheimer's Disease (2 active studies)
- Alzheimers Disease (2 active studies)
- Chronic Pain (2 active studies)
- Diffuse Large B-Cell Lymphoma (2 active studies)
Leading research sponsors in Clermont
- Merck Sharp & Dohme LLC
- Sanofi
- Boston Scientific Corporation
- Eli Lilly and Company
- 89bio, Inc.
Frequently asked questions
How many paid clinical trials are currently recruiting in Clermont?
There are approximately 42 recruiting clinical trials in Clermont, Florida listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Clermont pay participants?
Most recruiting trials in Clermont compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Clermont?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Clermont?
The most common conditions under active study in Clermont include Crohn's Disease (3), Non-Small Cell Lung Cancer (3), Alzheimer's Disease (2), Alzheimers Disease (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Clermont?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Clermont on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Clermont?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Clermont?
Recruiting research sites in Clermont include Clermont Oncology Center, K2 Medical Research - Winter Garden, Novum Research, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Clermont right now?
The largest active categories in Clermont are Cancer & tumors (12), Neurology & pain (4), Diabetes & metabolic (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Clermont Oncology Center?
Clermont Oncology Center is located at 255 CITRUS TOWER BLVD, SUITE 100, CLERMONT, FL 34711-2756. Use the Google Maps link in the intro above to get directions.
How do I contact Clermont Oncology Center?
You can reach Clermont Oncology Center by phone at (352) 536-6340. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.